The prevalence of chronic kidney disease (CKD), defined as a persistent decrease in GFR or increase in urinary albumin excretion by more than 25%, is increasing in parallel with the duration of diabetes despite the use of therapeutic agents [29,30]. This evidence concerns the gene ALB and chronic kidney disease.